Mechanisms underlying the cross-talk between heart and cancer

被引:17
作者
Brancaccio, Mara [1 ]
Pirozzi, Flora [2 ]
Hirsch, Emilio [1 ]
Ghigo, Alessandra [1 ]
机构
[1] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Mol Biotechnol Ctr, Via Nizza 52, I-10126 Turin, Italy
[2] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2020年 / 598卷 / 14期
关键词
heart failure; cancer; co-morbidities; inflammation; cross-talk; TUMOR-NECROSIS-FACTOR; CLONAL HEMATOPOIESIS; CARDIOVASCULAR-DISEASE; CARDIAC ATROPHY; FACTOR-ALPHA; ACTIVIN-A; DIASTOLIC DYSFUNCTION; METABOLIC DYSFUNCTION; CONTRACTILE FUNCTION; INDUCED CACHEXIA;
D O I
10.1113/JP276746
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cardiovascular diseases and cancer remain the leading cause of death worldwide. Despite the fact that these two conditions have long been considered as distinct clinical entities, recent epidemiological and experimental studies suggest that they should be contemplated and treated as co-morbidities. Heart failure represents nowadays a well-established complication of cancer, primarily as a consequence of the aggressive use of cardiotoxic anti-cancer treatments. On the other hand, the provocative idea that heart failure can prime carcinogenesis has started to emerge, though the molecular basis is still to be fully elucidated. This review summarizes the current knowledge on the mechanisms underlying the bidirectional communication between the failing heart and the cancer. We will discuss and/or speculate on the role of molecular mediators released by either the tumour or the heart that can potentially link heart failure and cancer.
引用
收藏
页码:3015 / 3027
页数:13
相关论文
共 100 条
[21]   Cancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner [J].
Cosper, Pippa F. ;
Leinwand, Leslie A. .
CANCER RESEARCH, 2011, 71 (05) :1710-1720
[22]   Metabolic changes of cancer cachexia - second of two parts [J].
De Blaauw, I ;
Deutz, NEP ;
Von Meyenfeldt, MF .
CLINICAL NUTRITION, 1997, 16 (05) :223-228
[23]   TNFR1 and TNFR2 signaling interplay in cardiac myocytes [J].
Defer, Nicole ;
Azroyan, Anie ;
Pecker, Francoise ;
Pavoine, Catherine .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (49) :35564-35573
[24]   Targeting lactate metabolism for cancer therapeutics [J].
Doherty, Joanne R. ;
Cleveland, John L. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (09) :3685-3692
[25]   Cytokines as therapeutic agents and targets in heart disease [J].
Dubnika, Arita ;
Manoukian, Martin A. C. ;
Mohammadi, M. Rezaa ;
Parekh, Mansi Bharat ;
Gurjarpadhye, Abhijit Achyut ;
Inayathullah, Mohammed ;
Dubniks, Viktors ;
Lakey, Jonathan R. T. ;
Rajadas, Jayakumar .
CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 43 :54-68
[26]  
Fang L, 2017, AM J TRANSL RES, V9, P5063
[27]   TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTORS IN PATIENTS WITH VARIOUS DEGREES OF CONGESTIVE-HEART-FAILURE [J].
FERRARI, R ;
BACHETTI, T ;
CONFORTINI, R ;
OPASICH, C ;
FEBO, O ;
CORTI, A ;
CASSANI, G ;
VISIOLI, O .
CIRCULATION, 1995, 92 (06) :1479-1486
[28]   Malignant Drosophila Tumors Interrupt Insulin Signaling to Induce Cachexia-like Wasting [J].
Figueroa-Clarevega, Alejandra ;
Bilder, David .
DEVELOPMENTAL CELL, 2015, 33 (01) :47-55
[29]   The varying faces of IL-6: From cardiac protection to cardiac failure [J].
Fontes, Jillian A. ;
Rose, Noel R. ;
Cihakova, Daniela .
CYTOKINE, 2015, 74 (01) :62-68
[30]   The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis [J].
Fusella, Federica ;
Secli, Laura ;
Busso, Elena ;
Krepelova, Anna ;
Moiso, Enrico ;
Rocca, Stefania ;
Conti, Laura ;
Annaratone, Laura ;
Rubinetto, Cristina ;
Mello-Grand, Maurizia ;
Singh, Vijay ;
Chiorino, Giovanna ;
Silengo, Lorenzo ;
Altruda, Fiorella ;
Turco, Emilia ;
Morotti, Alessandro ;
Oliviero, Salvatore ;
Castellano, Isabella ;
Cavallo, Federica ;
Provero, Paolo ;
Tarone, Guido ;
Brancaccio, Mara .
NATURE COMMUNICATIONS, 2017, 8